Description

The reprocessed device market will experience strong growth through 2013 as health care facilities increasingly adopt reprocessing in order to curb supply costs. In general, reprocessed devices cost about half the price of new devices. Facilities will be able to redirect the cost savings toward staffing, patient care services, medical technology, and research. As a result, original equipment manufacturers (OEMs) will lose significant revenue as reprocessed devices are increasingly purchased.

Report Highlights:

-Learn the legislative and regulatory victories for the reprocessed device market that will drive growth through 2013.

-Observe the rising penetration of reprocessed devices and the revenue losses of OEMs through 2013.

-Assess the impact of the Food and Drug Administration's approval for the reprocessing of new devices such as electrophysiology catheters.

-Understand that strong sales of reprocessed direct energy devices will occur due to their significant cost savings compared to the purchase of OEM products. Reprocessed direct energy devices will represent the largest segment of the reprocessed laparoscopic device market.